Study of N-Acetylcysteine in Acute Liver Failure (ALF)
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This proposed study is a multi-center open label study to determine if N-acetylcysteine has
any survival benefits in patients with acute liver failure.
Phase:
Phase 4
Details
Lead Sponsor:
University of Texas Southwestern Medical Center William Lee
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)